Jun Tang

5.0k citations
110 papers · 3.0k indexed · h-index 30
Topics
Breast Cancer Treatment Studies (12 papers)MicroRNA in disease regulation (12 papers)Breast Lesions and Carcinomas (9 papers)

In The Last Decade

Jun Tang

102 papers receiving 2.9k citations

Peers

Jun Tang
Comparison fields: 5 of 135
  • Molecular Biology 1.7k
  • Cancer Research 1.1k
  • Oncology 647
  • Epidemiology 464
  • Pulmonary and Respiratory Medicine 348
Replace Edward A. Ratovitski with:
Edward A. Ratovitski United States
Hua‐chuan Zheng China
Masashi Shiiba Japan
Jingwei Ma China
Charalambos Solomides United States
Chi‐Long Chen Taiwan
Jesús M. Paramio Spain
Aditi Chatterjee India
Shih Sheng Jiang Taiwan
Anamaria A. Camargo Brazil
Jun Tang relative to Edward A. Ratovitski United States Edward A. Ratovitski's profile →
Citations per field
00.5×3.8×
Edward A. Ratovitski · 1×
Citations per year

Countries citing papers authored by Jun Tang

Since Specialization
Citations

This map shows the geographic impact of Jun Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Tang more than expected).

Fields of papers citing papers by Jun Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Tang. The network helps show where Jun Tang may publish in the future.

Co-authorship network of co-authors of Jun Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Tang. A scholar is included among the top collaborators of Jun Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Tang. Jun Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 18
4 0
5 7
6 3
7 4
8 0
9 2
10 21
11 19
12 6
13 22
14 0
15
Research advance in self-incompatibility of Ipomoea trifida, an ancestor of sweet potato.
2
16 1
17 34
18 4
19 17
20
Research of Mobile Payment User and User Behavior
3

About Jun Tang

Jun Tang is a scholar working on Cancer Research, Otorhinolaryngology and Oncology, having authored 110 papers that have together received 3.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (12 papers), MicroRNA in disease regulation (12 papers) and Breast Lesions and Carcinomas (9 papers). The work is most often cited by research in Cancer Research (1.1k citations), Otorhinolaryngology (116 citations) and Molecular Biology (1.7k citations). Jun Tang has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Rong Deng, Dandan Li, Xiao‐Feng Zhu, Zhi‐Ling Li, Yun Huang, Xiao‐Feng Zhu, Gong‐Kan Feng, Xiaoming Xie, Xuan Li and Gong-Kan Feng. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Nano Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026